Building a Strong Patent Portfolio for Nucleic Acid-Based Inventions
Presented by IPLAC Biotech & Lathrop Gage
Please join us for an overview of the road from the bench to the marketplace for Nucleic Acid-Based Inventions. We will have a lively discussion about building a patent portfolio including maximizing Patent Term Adjustment and Patent Term Extension. Our exceptional panel of speakers includes: Dr. David Giljohann, Chief Executive Officer of Exicure; James Velema, Partner at Lathrop Gage LLP; and Dr. Laura Labeots, Partner at Lathrop Gage LLP.
Noon - 1:00 pm
Lathrop Gage LLP
155 N Wacker Drive, 2nd Flood Conf. Room
Chicago, IL 60606
Registration and Fees:
The fee is free for IPLAC members and non-members.
Please RSVP to email@example.com no later than July 15, 2019